The HEADWIND-Study

NCT04035993 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
26
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators